MedPath

Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB

Not Applicable
Completed
Conditions
Cancer Pain
Pancreatic Cancer
Biliary Tract Cancer
Depression
Interventions
Other: Early Palliative care integrated with usual oncologic care
Registration Number
NCT01589328
Lead Sponsor
National Cancer Center, Korea
Brief Summary

Effect of Early management on PAin and DEpression in patients with PancreatoBiliary Cancer, EPADE-PB

Purpose

To determine whether early palliative care integrated with usual oncologic care with automated symptom monitoring can improve depression and pain in patients with cancer

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
288
Inclusion Criteria
  • Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No
  • Pathologic confirmed locally advanced or metastatic pancreatic cancer or biliary tract cancer
  • within 8 weeks after diagnosis
  • cancer-related pain (Brief Pain Inventory [BPI] worst pain score >3), depression (Center for Epidemiological Studies-Depression Scale [CES-D] >16) or both
  • Karnofsky Performance Rating Scale ≥50%
Exclusion Criteria
  • Opioid intolerance
  • History of drug or alcohol abuse
  • Impaired sensory or cognitive function
  • Pregnant or lactating woman
  • Women of child bearing potential not using a contraceptive method
  • Sexually active fertile men not using effective birth control during medication of study drug and up to 6 months after completion of study drug if their partners are women of child-bearing potential

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Early Palliative careEarly Palliative care integrated with usual oncologic careThe interventions consisted of the following: (1) Nursing assessment of pain and depression mood (2) Pain control based NCCN guideline (3) Depression control by psychoeducation and/or consultation of psychiatrist specialist (4) Patient education
Primary Outcome Measures
NameTimeMethod
Reduction in depression scoreat baseline, 1 month, and every 3 months, up to 1 year

Reduction in depression score, Center for Epidemiological Studies-Depression Scale \[CES-D\]

Reduction in pain scoreat baseline, 1 month, and every 3 months, up to 1 year

• Reduction in pain scores, Brief Pain Inventory \[BPI\] severity

Secondary Outcome Measures
NameTimeMethod
Quality of lifeat baseline, 1 month, and every 3 months, up to 1 year

EORTC QLQ-C30 General Questionnaire, Korean version

Overall survivalat baseline, 1 month, and every 3 months, up to 1 year

Trial Locations

Locations (1)

National Cancer Center

🇰🇷

Goyang, 410-769, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath